Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Search Results: PARP

Showing 12 out of 142 results
Cancer Research UK logo

ROUTINELY testing for a faulty BRCA2 gene in under-65s with prostate cancer could help identify men who could benefit from new types of targeted treatment, new research published in the British Journal of Cancer* today shows. ROUTINELY testing for a faulty BRCA2 gene in under-65s with prostate cancer could help identify men who could benefit from new types of targeted treatment, new research published in the British Journal of Cancer* today shows.

by British Journal of Cancer | News | 12 October 2011

12 October 2011

Cancer Research UK logo

Cancer Research UK scientists have succeeded in purifying a protein found in bacteria that could reveal new drug targets for inherited breast and ovarian cancers - and other cancers linked to DNA repair faults. The study is published in the journal Nature today (Sunday). Cancer Research UK scientists have succeeded in purifying a protein found in bacteria that could reveal new drug targets for inherited breast and ovarian cancers - and other cancers linked to DNA repair faults. The study is published in the journal Nature today (Sunday).

by Cancer Research UK | News | 4 September 2011

4 September 2011

Cancer Research UK logo

A Cancer Research UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford. A Cancer Research UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford.

by Cancer Research UK | News | 17 August 2011

17 August 2011

Cancer Research UK logo

Cancer Research UK-funded scientists have discovered that women who carry a faulty copy of a gene called RAD51D have almost a one in 11 chance of developing ovarian cancer, the most significant ovarian cancer gene discovery for more than a decade, reveals a study in Nature Genetics today. Cancer Research UK-funded scientists have discovered that women who carry a faulty copy of a gene called RAD51D have almost a one in 11 chance of developing ovarian cancer, the most significant ovarian cancer gene discovery for more than a decade, reveals a study in Nature Genetics today.

by Cancer Research UK | News | 7 August 2011

7 August 2011

Cancer Research UK logo

Cancer Research UK scientists at Newcastle University and researchers based at Harvard University have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors. The research is published in Nature Medicine today. Cancer Research UK scientists at Newcastle University and researchers based at Harvard University have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors. The research is published in Nature Medicine today.

by Cancer Research UK | News | 26 June 2011

26 June 2011

Cancer Research UK logo
  • Science & Technology
  • Health & Medicine

ASCO 2011 – conference highlights

Our senior science information manager Julie Sharp talks to Harpal Kumar, Cancer Research UK’s chief executive about the big stories. Our senior science information manager Julie Sharp talks to Harpal Kumar, Cancer Research UK’s chief executive about the big stories.

by Julie Sharp | Analysis | 15 June 2011

15 June 2011